Trial Profile
A new dosing strategy of infliximab versus standard dosing in patients with severe sarcoidosis: optimization of treatment
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 13 May 2015 New trial record